Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Lúcuma (Pouteria lucuma) is a nutrient-dense Andean fruit rich in polyphenols (taxifolin, gallocatechin), carotenoids, and dietary fiber that exhibits potent antioxidant capacity of up to 3.53 mM Trolox equivalents via DPPH assay and significant in vitro alpha-glucosidase and ACE inhibitory activity relevant to blood sugar and blood pressure management (PMID 29555072; PMID 19459727). Its nut oil has been shown to significantly accelerate wound closure in fibroblast cell cultures by up to 60% compared to controls, supporting dermatological applications, while its seeds contain bioactive compounds with demonstrated antibacterial and antioxidant properties (PMID 20883291; PMID 31079645).
Reported Benefits (Provisional)
Origin & History
Lúcuma (Pouteria lucuma) is a subtropical fruit native to the Andean highlands of Peru, Ecuador, and Chile, thriving in temperate valleys with nutrient-rich volcanic soils and elevations ranging from 1,000 to 2,400 meters. Known as the “Gold of the Incas,” this sacred fruit has been revered for centuries for its nourishing sweetness and health-enhancing properties.
Research Narrative (Provisional)
Pinto et al. (2009) in the Journal of Medicinal Food (PMID 19459727) demonstrated that lúcuma pulp possesses significant alpha-glucosidase inhibitory activity (antihyperglycemic potential) and ACE inhibitory activity (antihypertensive potential) using in vitro enzyme assays of native Peruvian fruits. Rojo et al. (2010) in the Journal of Cosmetic Dermatology (PMID 20883291) showed that Pouteria lucuma nut oil promoted wound closure in fibroblast monolayers, increasing wound-healing rates by approximately 60% over untreated controls, with effects attributed to its fatty acid and phytosterol composition. Campos et al. (2018) in Advances in Food and Nutrition Research (PMID 29555072) characterized lúcuma's polyphenol profile—including taxifolin and gallocatechin—and reported DPPH radical scavenging activity of up to 3.53 mM Trolox equivalents, establishing it among the most antioxidant-rich Andean fruits. Guerrero-Castillo et al. (2019) in Waste Management (PMID 31079645) provided the first comprehensive biological characterization of Pouteria lucuma seeds, identifying significant antibacterial activity against Staphylococcus aureus and antioxidant potential, suggesting valorization of this agricultural byproduct.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Complex Carbohydrates: Provide slow-releasing, sustained energy. - Dietary Fiber: Regulates digestion, satiety, and blood sugar. - Vitamin A (beta-carotene): Supports skin renewal and eye health. - Vitamin C: Promotes collagen synthesis and immune defense. - B Vitamins (B3, B5): Aid energy metabolism and hormonal balance. - Minerals: Iron, zinc, and calcium support immunity, bone strength, and tissue regeneration.
Reported Mechanism (Provisional)
Lúcuma's principal polyphenols—taxifolin (dihydroquercetin) and gallocatechin—neutralize reactive oxygen species (ROS) via both hydrogen atom transfer (HAT) and single electron transfer (SET) mechanisms, yielding DPPH radical scavenging activity of up to 3.53 mM Trolox equivalents (PMID 29555072). Its antihyperglycemic effect is mediated through competitive inhibition of alpha-glucosidase, the brush-border enzyme responsible for cleaving disaccharides into absorbable monosaccharides, thereby delaying postprandial glucose absorption (PMID 19459727). The ACE inhibitory activity arises from peptide and polyphenol fractions that bind the zinc-containing active site of angiotensin-converting enzyme, reducing conversion of angiotensin I to angiotensin II and thus lowering peripheral vascular resistance (PMID 19459727). Additionally, triterpenoids—including novel 13,27-cycloursane-type compounds isolated from Pouteria lucuma leaves—may contribute anti-inflammatory bioactivity through modulation of NF-κB and cyclooxygenase pathways (PMID 31121254).
Clinical Narrative (Provisional)
Current evidence for lúcuma is limited to in vitro studies and metabolite profiling rather than human clinical trials. A 2021 study using HR-LC-ESI-Orbitrap-MS identified 36 bioactive compounds in pulp extracts, with skin showing particularly high phenolic content at 560.69 mg GAE/g extract. Laboratory assays demonstrate antioxidant activity through DPPH and TEAC measurements, with taxifolin showing the highest radical scavenging capacity. While Bolivian nutritional analysis revealed a favorable omega-6:omega-3 ratio of 0.21, human trials with quantified health outcomes are needed to validate therapeutic claims.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.